CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.

about

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.

Item

http://www.wikidata.org/entity/Q54950777

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.

@en

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.

@nl

type

Item

label

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.

@en

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.

@nl

prefLabel

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.

@en

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.

@nl

P1476

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.

@en

P2093

Feng Lin

http://www.w3.org/2001/XMLSchema#string

Juying Han

http://www.w3.org/2001/XMLSchema#string

P2860

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

The effects of diet-induced obesity on B cell function

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

B cells and atherosclerosis.

Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab

The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.

Adaptive Response of T and B Cells in Atherosclerosis.

Genetic-genomic replication to identify candidate mouse atherosclerosis modifier genes.

A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.

P2888

s13104-018-3327-4

P304

229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13104-018-3327-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan D Smith

Gospel Enyindah-Asonye

P577

2018-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103148496

http://www.w3.org/2001/XMLSchema#string

P698

29615096

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

5883413

http://www.w3.org/2001/XMLSchema#string